Shanghai Medicilon, Inc.SSE: 688202

(688202)"Shanghai Medicilon Inc."Announcement on Satisfaction of Vesting Conditions for the First Vesting Period of the Initial Grant and Reserved Grant under the 2025 Restricted Share Incentive Plan

· Issued by Shanghai Medicilon, Inc. via Shanghai Stock Exchange

Filed with SSE · Stock code 688202 · · 10 pages · Chinese

Summary by 6ix AI

The company reports that a total of a certain number of shares will be vested, with a breakdown between initial and reserved grants. The board has confirmed that the conditions for vesting have been met for a specified number of incentive recipients, allowing for the processing of their share allocations. The announcement includes details on the approval and implementation of the incentive plan, as well as the performance conditions required for vesting.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688202shanghai-medicilon-incannouncement-on-satisfaction-of-vesting-conditions-for-the-first-vesting-period-of-the-initial-grant-and-reserved-grant-under-the-2025-restricted-share-incentive-plan

Release

Announcement on Satisfaction of Vesting Conditions for the First Vesting Period of the Initial Grant and Reserved Grant under the 2025 Restricted Share Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Shanghai Medicilon, Inc. on 6ix

Story so far

Earlier from Shanghai Medicilon

Later from Shanghai Medicilon

All Shanghai Medicilon news releases